Montaldo PG - Search Results

1

Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.

Pastorino F, Di Paolo D, Loi M, Becherini P, Caffa I, Zorzoli A, Marimpietri D, Carosio R, Perri P, Montaldo PG, Brignole C, Pagnan G, Ribatti D, Allen TM, Ponzoni M. Pastorino F, et al. Among authors: montaldo pg. Curr Drug Targets. 2009 Oct;10(10):1021-7. doi: 10.2174/138945009789577954. Curr Drug Targets. 2009. PMID: 19663770 Review.

2

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

Pagnan G, Stuart DD, Pastorino F, Raffaghello L, Montaldo PG, Allen TM, Calabretta B, Ponzoni M. Pagnan G, et al. Among authors: montaldo pg. J Natl Cancer Inst. 2000 Feb 2;92(3):253-61. doi: 10.1093/jnci/92.3.253. J Natl Cancer Inst. 2000. PMID: 10655443

3

Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.

Raffaghello L, Pagnan G, Pastorino F, Cosimo E, Brignole C, Marimpietri D, Bogenmann E, Ponzoni M, Montaldo PG. Raffaghello L, et al. Among authors: montaldo pg. Cancer Lett. 2003 Jul 18;197(1-2):151-5. doi: 10.1016/s0304-3835(03)00097-1. Cancer Lett. 2003. PMID: 12880975 Review.

4

In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.

Raffaghello L, Pagnan G, Pastorino F, Cosimo E, Brignole C, Marimpietri D, Montaldo PG, Gambini C, Allen TM, Bogenmann E, Ponzoni M. Raffaghello L, et al. Among authors: montaldo pg. Int J Cancer. 2003 May 1;104(5):559-67. doi: 10.1002/ijc.10991. Int J Cancer. 2003. PMID: 12594810

5

Fenretinide as an anti-angiogenic agent in neuroblastoma.

Ribatti D, Raffaghello L, Marimpietri D, Cosimo E, Montaldo PG, Nico B, Vacca A, Ponzoni M. Ribatti D, et al. Among authors: montaldo pg. Cancer Lett. 2003 Jul 18;197(1-2):181-4. doi: 10.1016/s0304-3835(03)00105-8. Cancer Lett. 2003. PMID: 12880979 Review.

6

N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death.

Montaldo PG, Pagnan G, Pastorino F, Chiesa V, Raffaghello L, Kirchmeier M, Allen TM, Ponzoni M. Montaldo PG, et al. Int J Cancer. 1999 Apr 12;81(2):262-7. doi: 10.1002/(sici)1097-0215(19990412)81:2<262::aid-ijc16>3.0.co;2-a. Int J Cancer. 1999. PMID: 10188729

7

GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide.

Pagnan G, Montaldo PG, Pastorino F, Raffaghello L, Kirchmeier M, Allen TM, Ponzoni M. Pagnan G, et al. Among authors: montaldo pg. Int J Cancer. 1999 Apr 12;81(2):268-74. doi: 10.1002/(sici)1097-0215(19990412)81:2<268::aid-ijc17>3.0.co;2-1. Int J Cancer. 1999. PMID: 10188730

8

Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse.

Raffaghello L, Marimpietri D, Pagnan G, Pastorino F, Cosimo E, Brignole C, Ponzoni M, Montaldo PG. Raffaghello L, et al. Among authors: montaldo pg. Cancer Lett. 2003 Jul 18;197(1-2):205-9. doi: 10.1016/s0304-3835(03)00100-9. Cancer Lett. 2003. PMID: 12880983 Review.

9

In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.

Montaldo PG, Carbone R, Lanciotti M, Ponzoni M, Cornaglia-Ferraris P. Montaldo PG, et al. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):195-8. J Nucl Biol Med (1991). 1991. PMID: 1823817

10

Interferon-gamma-induced differentiation of human neuroblastoma cells increases cellular uptake and halflife of metaiodobenzylguanidine.

Montaldo PG, Carbone R, Cornaglia Ferraris P, Ponzoni M. Montaldo PG, et al. Cytotechnology. 1993;11 Suppl 1:S140-3. Cytotechnology. 1993. PMID: 7763744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters